Company News
-
November 28, 2024
With E-Resale, bioMérieux innovates by giving a second life to its instruments
Launched last July, starting with Africa and Middle East, the E-Resale platform allows to purchase and sell second-hand bioMérieux instruments for clinical applications. This is an innovative offer in the field of circular economy and a first on the in vitro diagnostics market. -
November 22, 2024
bioMérieux and St James’s Hospital in Ireland announce the world-first Data & IT Centre of Reference partnership
On November 14th, 2024, bioMérieux officially launched its first Data & IT Centre of Reference partnership with St James's Hospital in Dublin, Ireland. This landmark collaboration has been celebrated with an event held at the Davis Coakley Lecture Theatre, St James's Hospital. -
November 21, 2024
A 100% digital campaign to raise awareness about antimicrobial resistance
Globally, it was estimated that approximately 4.95 million people died from Antimicrobial Resistance-related causes in 2019. And yet, one in three adults doesn’t understand what this term means. Faced with this alarming situation, an awareness-raising campaign encourages the general public to change their behaviour with regard to the use of antibiotics. Indeed, each person, at their own level, has a role to play to preserve their effectiveness. -
November 15, 2024
Canada's First Center of Excellence in the Fight Against Antimicrobial Resistance
On November 11, 2024, the Université de Sherbrooke (UdeS), the Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS) and bioMérieux, a world leader in the field of in vitro diagnostics, announce a three-year agreement to create a Canadian center of excellence dedicated to the fight against antimicrobial resistance and antibiotic stewardship. -
October 10, 2024
Advancing the Global AMR Agenda: A Call for Multi-Sector Collaboration
On the sidelines of the 2024 United Nations High-Level Meeting on Antimicrobial Resistance (AMR), a multisectoral event titled “Advancing Together: Securing the Global AMR Agenda by Harnessing the Collective Strength of Multi-Sector Partnerships” took place on September 24 in New York. bioMérieux, in partnership with The Wellcome Trust, The American Society of Microbiology, Malawi, and the French Republic, organized the event to focus on fostering a collaborative ecosystem that establishes sustainable solutions across the entire AMR landscape. From diagnosis and treatment to surveillance and action plans, this initiative spanned human health, animals, and the environment.